Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.

Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH.

Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.

2.

Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.

Mazumder A, Wang S, Neamati N, Nicklaus M, Sunder S, Chen J, Milne GW, Rice WG, Burke TR Jr, Pommier Y.

J Med Chem. 1996 Jun 21;39(13):2472-81.

PMID:
8691444
4.

Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase.

Mazumder A, Gazit A, Levitzki A, Nicklaus M, Yung J, Kohlhagen G, Pommier Y.

Biochemistry. 1995 Nov 21;34(46):15111-22.

PMID:
7578125
5.

Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.

Mazumder A, Neamati N, Sommadossi JP, Gosselin G, Schinazi RF, Imbach JL, Pommier Y.

Mol Pharmacol. 1996 Apr;49(4):621-8.

PMID:
8609889
6.

Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.

Robinson WE Jr, Cordeiro M, Abdel-Malek S, Jia Q, Chow SA, Reinecke MG, Mitchell WM.

Mol Pharmacol. 1996 Oct;50(4):846-55.

PMID:
8863829
7.

(-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase.

Eich E, Pertz H, Kaloga M, Schulz J, Fesen MR, Mazumder A, Pommier Y.

J Med Chem. 1996 Jan 5;39(1):86-95.

PMID:
8568830
8.

Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues.

Jenkins TM, Hickman AB, Dyda F, Ghirlando R, Davies DR, Craigie R.

Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):6057-61.

9.
10.

Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli.

Vink C, van der Linden KH, Plasterk RH.

J Virol. 1994 Mar;68(3):1468-74.

12.

Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate.

Mazumder A, Cooney D, Agbaria R, Gupta M, Pommier Y.

Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5771-5.

13.

HIV-1 integrase: the next target for AIDS therapy?

d'Angelo J, Mouscadet JF, Desmaële D, Zouhiri F, Leh H.

Pathol Biol (Paris). 2001 Apr;49(3):237-46. Review.

PMID:
11367559
16.

Role of the 207-218 peptide region of Moloney murine leukemia virus integrase in enzyme catalysis.

Acevedo ML, Arbildúa JJ, Monasterio O, Toledo H, León O.

Arch Biochem Biophys. 2010 Mar 1;495(1):28-34. doi: 10.1016/j.abb.2009.12.018. Epub 2009 Dec 21.

PMID:
20026028
17.

A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.

de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.

J Mol Biol. 2002 Apr 19;318(1):45-58.

PMID:
12054767
19.

Inhibitors of human immunodeficiency virus integrase.

Fesen MR, Kohn KW, Leteurtre F, Pommier Y.

Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2399-403.

Supplemental Content

Support Center